What we do
Precision oncology
We conduct cancer research focused on understanding the unique genetics and drug sensitivities that influence cancer treatment in African populations. Through inclusive science, innovation and data-driven health solutions, we aim to advance equitable and effective diagnostics and treatments. Using our novel drug sensitivity test, we are transforming access to cancer care in Africa and beyond.
Precision oncology
We conduct cancer research focused on understanding the unique genetics and drug sensitivities that influence cancer treatment in African populations. Through inclusive science, innovation and data-driven health solutions, we aim to advance equitable and effective diagnostics and treatments. Using our novel drug sensitivity test, we are transforming access to cancer care in Africa and beyond.
Precision oncology
We conduct cancer research focused on understanding the unique genetics and drug sensitivities that influence cancer treatment in African populations. Through inclusive science, innovation and data-driven health solutions, we aim to advance equitable and effective diagnostics and treatments. Using our novel drug sensitivity test, we are transforming access to cancer care in Africa and beyond.
Precision oncology
We conduct cancer research focused on understanding the unique genetics and drug sensitivities that influence cancer treatment in African populations. Through inclusive science, innovation and data-driven health solutions, we aim to advance equitable and effective diagnostics and treatments. Using our novel drug sensitivity test, we are transforming access to cancer care in Africa and beyond.
Precision oncology
We conduct cancer research focused on understanding the unique genetics and drug sensitivities that influence cancer treatment in African populations. Through inclusive science, innovation and data-driven health solutions, we aim to advance equitable and effective diagnostics and treatments. Using our novel drug sensitivity test, we are transforming access to cancer care in Africa and beyond.
Precision oncology
We conduct cancer research focused on understanding the unique genetics and drug sensitivities that influence cancer treatment in African populations. Through inclusive science, innovation and data-driven health solutions, we aim to advance equitable and effective diagnostics and treatments. Using our novel drug sensitivity test, we are transforming access to cancer care in Africa and beyond.
Contact information:
Highlights
Collaboration pioneers personalised leukaemia treatment for Africa
The CSIR, in collaboration with clinicians from the University of the Witwatersrand (Wits) at Chris Hani Baragwanath Academic Hospital and the Wits Donald Gordon Medical Centre, has developed an innovative ex vivo drug sensitivity testing platform. This pilot study marks a significant step forward in precision medicine for leukaemia patients in South Africa, offering the promise of more tailored and effective treatment options for individuals diagnosed with this aggressive blood cancer.
Personalised chemo for African patients
In a first for Africa, researchers are screening cancer tissue samples to identify existing drugs that could be repurposed as effective chemotherapies for people of African descent. The CSIR and University of Pretoria are building a database using tumor samples donated by consenting patients at Steve Biko Academic Hospital, aiming to enable future patients in Africa to access personalised cancer medicines. Read more or watch a video.
Capabilities
Our facilities
